J.P. Morgan Private Wealth Advisors LLC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 77 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
J.P. Morgan Private Wealth Advisors LLC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q2 2022$19,000
-9.5%
16,1670.0%0.00%
Q1 2022$21,000
-25.0%
16,1670.0%0.00%
Q4 2021$28,000
-49.1%
16,167
-35.8%
0.00%
Q3 2021$55,000
-36.0%
25,170
+2.7%
0.00%
Q2 2021$86,000
-47.6%
24,509
+47.0%
0.00%
-100.0%
Q1 2021$164,000
-10.9%
16,670
-2.0%
0.00%0.0%
Q4 2020$184,000
+14.3%
17,009
+8.5%
0.00%0.0%
Q3 2020$161,000
-50.8%
15,6700.0%0.00%0.0%
Q2 2020$327,000
+67.7%
15,670
-21.6%
0.00%0.0%
Q1 2020$195,000
-15.2%
20,0000.0%0.00%0.0%
Q4 2019$230,000
+111.0%
20,0000.0%0.00%0.0%
Q3 2019$109,000
-54.2%
20,0000.0%0.00%0.0%
Q2 2019$238,000
+126.7%
20,0000.0%0.00%0.0%
Q1 2019$105,000
+66.7%
20,0000.0%0.00%
Q4 2018$63,000
-47.9%
20,0000.0%0.00%
-100.0%
Q3 2018$121,000
+14.2%
20,0000.0%0.00%0.0%
Q2 2018$106,000
-8.6%
20,0000.0%0.00%0.0%
Q1 2018$116,000
+65.7%
20,0000.0%0.00%
Q4 2017$70,000
-4.1%
20,0000.0%0.00%
-100.0%
Q3 2017$73,000
+46.0%
20,0000.0%0.00%
Q2 2017$50,000
-7.4%
20,0000.0%0.00%
Q1 2017$54,000
-6.9%
20,0000.0%0.00%
-100.0%
Q4 2016$58,000
-29.3%
20,0000.0%0.00%0.0%
Q3 2016$82,000
+30.2%
20,0000.0%0.00%0.0%
Q2 2016$63,00020,0000.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q2 2016
NameSharesValueWeighting ↓
Casdin Capital, LLC 420,000$1,134,0000.67%
EcoR1 Capital, LLC 874,447$2,361,0000.60%
VHCP Management II, LLC 280,000$756,0000.31%
683 Capital Management, LLC 350,000$945,0000.15%
AWM Investment Company, Inc. 400,000$1,080,0000.10%
JW Asset Management, LLC 178,654$482,0000.10%
TFS CAPITAL LLC 89,156$241,0000.08%
Rhenman & Partners Asset Management AB 154,006$416,0000.07%
SABBY MANAGEMENT, LLC 282,630$763,0000.04%
Numeric Investors LLC 1,087,967$2,938,0000.03%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders